YAVNE, Israel, June 10, 2016, ORBK, /PRNewswire/ — ORBOTECH LTD. (the “Company” or “Orbotech“) (NASDAQ/GSM: ORBK) announced today that its previously announced public offering of 3,850,000 ordinary shares (the “Offering“) was priced at a price to the public of $26.52 per share. The gross proceeds from the Offering before expenses are expected to be approximately$102.1 million. The Company has also granted the underwriter an option to purchase up to 385,000 additional ordinary shares. The Company plans to use the proceeds ofRead more
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
- Pura Naturals Launches New Line of Health and Beauty Products with CBD and Hemp Seed Oils
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
- Sugarmade to Offer Revenue Guidance on March 30th for Rapid Cannabis Sector Growth – Begins to Recognize Revenues From Multiple New Revenue Streams
- Sack Lunch Productions Reduces Debt by an Estimated $2M in Q1
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More